| # | Drug | Count |
|---|---|---|
| 0 | ALEMTUZUMAB | 3 |
| 1 | CLOPIDOGREL | 3 |
| 2 | CLOPIDOGREL BISULFATE | 3 |
| 3 | LEVOTHYROXINE SODIUM | 3 |
| 4 | ANTIHEMOPHILIC FACTOR (RECOMBINANT), PORCINE SEQUENCE | 2 |
| 5 | APIXABAN | 2 |
| 6 | ACETAMINOPHEN | 1 |
| 7 | ACETAMINOPHEN 500MG | 1 |
| 8 | ACETAMINOPHEN TABLET EXTENDED RELEASE | 1 |
| 9 | ADO-TRASTUZUMAB EMTANSINE | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ANTIHEMOPHILIC FACTOR (RECOMBINANT), PORCINE SEQUENCE | 2 | 0.0130 |
| 1 | ANTIHEMOPHILIC FACTOR HUMAN | 1 | 0.0007 |
| 2 | ANTIHEMOPHILIC FACTOR (RECOMBINANT), FC FUSION PROTEIN | 1 | 0.0003 |
| 3 | ALEMTUZUMAB | 3 | 0.0002 |
| 4 | ADO-TRASTUZUMAB EMTANSINE | 1 | 0.0001 |
| 5 | NALTREXONE | 1 | 0.0000 |
| 6 | CETIRIZINE HYDROCHLORIDE TABLETS | 1 | 0.0000 |
| 7 | APIXABAN | 2 | 0.0000 |
| 8 | CLOPIDOGREL BISULFATE | 3 | 0.0000 |
| 9 | GLIMEPIRIDE | 1 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD52-directed Cytolytic Antibody [EPC] | 3 | 0.0002 |
| 1 | P2Y12 Platelet Inhibitor [EPC] | 3 | 0.0000 |
| 2 | CTLA-4-directed Blocking Antibody [EPC] | 1 | 0.0000 |
| 3 | Integrin Receptor Antagonist [EPC] | 1 | 0.0000 |
| 4 | Nitrate Vasodilator [EPC] | 1 | 0.0000 |
| 5 | gamma-Aminobutyric Acid-ergic Agonist [EPC] | 1 | 0.0000 |
| 6 | Factor Xa Inhibitor [EPC] | 3 | 0.0000 |
| 7 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 1 | 0.0000 |
| 8 | Sulfonylurea [EPC] | 1 | 0.0000 |
| 9 | Interferon beta [EPC] | 1 | 0.0000 |